NU:NYSENu Holdings Ltd. Analysis
Data as of 2026-08-17 - not real-time
$15.02
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Nu Holdings Ltd. is priced at $15.02, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 6.8%. Momentum indicators put RSI at 61.8 (approaching overbought) with MACD reading bullish. Price has been bracketed by support at $13.37 and resistance at $16.22.
The shares look fair, trading on 20.6 times earnings above a sector average of 17.0. Consensus targets land 22.9% above where the shares trade now. Revenue is growing at 52.1% on a 42.7% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 41.2%, a beta of 1.36 and a maximum drawdown of 38.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
The shares look fair, trading on 20.6 times earnings above a sector average of 17.0. Consensus targets land 22.9% above where the shares trade now. Revenue is growing at 52.1% on a 42.7% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 41.2%, a beta of 1.36 and a maximum drawdown of 38.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
These catalysts could prove to be the actual drivers of the stock.Nu Holdings Ltd. NYSE:NU has declined roughly 25% year-to-date, however, the Street sees more than 41% upside from...2dNu Holdings Q2: The First Billion-Dollar Quarter Deserves A Buy RatingB+ net income, 39% revenue growth, 139M...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 15.05
- MACD momentum is positive
- 30-day price change of +6.8%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 20.6 versus sector average of 17.0
- Trading below the 200-day average of 15.05
- Analyst targets imply +22.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 20.6 versus sector average of 17.0
- Analyst targets imply +22.9% versus the current price
- Profit margin of 42.7% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth52.10%
Profit Margin42.73%
P/E Ratio20.6
ROE31.63%
ROA4.96%
P/B Ratio5.8
Op. Cash Flow$-10304786432
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI61.8
Support$13.37
Resistance$16.22
MA 20$14.29
MA 50$13.52
MA 200$15.05
MACDBullish
VolumeDecreasing
Fear & Greed Index94.61
Valuation
Target Price$18.45
Upside/Downside22.88%
GradeFair
TypeGrowth
Risk Assessment
Beta1.36
Volatility41.16%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.